Erratum to: High expression of the Ets-related gene (ERG) is an independent prognostic marker for relapse-free survival in patients with acute promyelocytic leukemia (Annals of Hematology DOI: 10.1007/s00277-012-1648-2);High expression of the Ets-related gene (ERG) is an independent prognostic marker for relapse-free survival in patients with acute promyelocytic leukemia

Annals of Hematology

Volumn 92, Issue 4, 2013, Pages 443-449

  Hecht, Anna ^a   Nowak, Daniel ^a   Nowak, Verena ^a   Hanfstein, Benjamin ^a   Faldum, Andreas ^b   Büchner, Thomas ^b   Spiekermann, Karsten ^c   Sauerland, Cristina ^b   Lengfelder, Eva ^a   Hofmann, Wolf Karsten ^a   Nolte, Florian ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF MUNICH   (Germany)

Author keywords

Acute promyelocytic leukemia; ERG expression; Overall survival; Prognosis; Relapse

Indexed keywords

MOLECULAR MARKER; ERG PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; ETS RELATED GENE; FEMALE; GENE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LEUKEMIA REMISSION; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; RECURRENCE FREE SURVIVAL; RISK ASSESSMENT; CASE CONTROL STUDY; DISEASE FREE SURVIVAL; GENE EXPRESSION REGULATION; GENETICS; MIDDLE AGED; MORTALITY; PROGNOSIS; RECURRENT DISEASE; RETROSPECTIVE STUDY; SURVIVAL; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEUKEMIA, PROMYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

MLCS; MLOWN;

EID: 84877050094     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-014-2101-5     Document Type: Erratum

References (19)

1. Grisolano JL, Wesselschmidt RL, Pelicci PG, Ley TJ (1997) Altered myeloid development and acute leukemia in transgenic mice expressing PML-RAR alpha under control of cathepsin G regulatory sequences. Blood 89:376-387
2. Brown D, Kogan S, Lagasse E et al (1997) A PMLRARα transgene initiates murine acute promyelocytic leukemia. Proc Natl Acad Sci U S A 94:2551-2556
3. Ades L, Guerci A, Raffoux E et al (2010) Very long-term outcome of acute promyelocytic leukemia after treatment with all-trans retinoic acid and chemotherapy: the European APL Group experience. Blood 115:1690-1696
4. Sanz MA, Lo Coco F, Martin G et al (2000) Definition of relapse risk and role of nonanthracycline drugs for consolidation in patients with acute promyelocytic leukemia: a joint study of the PETHEMA and GIMEMA cooperative groups. Blood 96:1247-1253
5. Lengfelder E, Haferlach C, Saussele S et al (2009) High dose ara-C in the treatment of newly diagnosed acute promyelocytic leukemia: long-term results of the German AMLCG. Leukemia 23:2248-2258
6. Ichikawa H, Shimizu K, Hayashi Y, Ohki M (1994) An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid leukemia with t(16;21) chromosomal translocation. Cancer Res 54:2865-2868
7. Welford SM, Hebert SP, Deneen B et al (2001) DNA binding domain-independent pathways are involved in EWS/FLI1-mediated oncogenesis. J Biol Chem 276:41977-41984
8. Kuhnl A, Gokbuget N, Stroux A et al (2010) High BAALC expression predicts chemoresistance in adult B-precursor acute lymphoblastic leukemia. Blood 115:3737-3744
9. Baldus CD, Burmeister T, Martus P et al (2006) High expression of the ETS transcription factor ERG predicts adverse outcome in acute T-lymphoblastic leukemia in adults. J Clin Oncol 24:4714-4720
10. Marcucci G, Maharry K, Whitman SP et al (2007) High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol 25:3337-3343
11. Metzeler KH, Dufour A, Benthaus T et al (2009) ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays. J Clin Oncol 27:5031-5038
12. Lengfelder E, Hanfstein B, Haferlach C et al (2012) Outcome of elderly patients with acute promyelocytic leukemia: results of the German Acute Myeloid Leukemia Cooperative Group. Ann Hematol. doi: 10.1007/s00277-012-1597-9
13. Pfaffl MW (2001) A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
14. Akagi T, Shih LY, Kato M et al (2009) Hidden abnormalities and novel classification of t(15;17) acute promyelocytic leukemia (APL) based on genomic alterations. Blood 113:1741-1748
15. Yaghmaie M, Mozdarani H, Alimoghaddam K et al (2012) Characterization of arsenic-induced cytogenetic alterations in acute promyelocytic leukemia cell line, NB4. Med Oncol 29:1209-1216
16. de la Serna J, Montesinos P, Vellenga E et al (2008) Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin. Blood 111:3395-3402
17. Lehmann S, Ravn A, Carlsson L et al (2011) Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry. Leukemia 25:1128-1134
18. Damm F, Heuser M, Morgan M et al (2011) Integrative prognostic risk score in acute myeloid leukemia with normal karyotype. Blood 117:4561-4568
19. Baldus CD, Martus P, Burmeister T et al (2007) Low ERG and BAALC expression identifies a new subgroup of adult acute T-lymphoblastic leukemia with a highly favorable outcome. J Clin Oncol 25:3739-3745